has been cited by the following article(s):
|
[1]
|
Acute rate control in atrial fibrillation: an urgent need for the clinician
European Heart Journal Supplements,
2022
DOI:10.1093/eurheartjsupp/suac022
|
|
|
|
|
[2]
|
Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis
European Journal of Clinical Pharmacology,
2022
DOI:10.1007/s00228-022-03383-2
|
|
|
|
|
[3]
|
A landiolol alkalmazási lehetőségei a kardiológiai és intenzív terápiás ellátásban
Orvosi Hetilap,
2022
DOI:10.1556/650.2022.32347
|
|
|
|
|
[4]
|
Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
Scientific Reports,
2019
DOI:10.1038/s41598-019-41520-7
|
|
|
|
|
[5]
|
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
Trials,
2019
DOI:10.1186/s13063-019-3904-4
|
|
|
|
|
[6]
|
Landiolol for managing post-operative atrial fibrillation
European Heart Journal Supplements,
2018
DOI:10.1093/eurheartj/sux036
|
|
|
|
|
[7]
|
Landiolol: A Review in Tachyarrhythmias
Drugs,
2018
DOI:10.1007/s40265-018-0883-9
|
|
|
|